Optimum initiation-time of direct-acting antivirals for hepatitis C after curative ablation of hepatocellular carcinoma improves neoplastic recurrence-free survival
Ahmed A. Elhadidy, A. Selim, M. Sarhan, M. Mabrouk, Heba Samier, A. Elsawy
{"title":"Optimum initiation-time of direct-acting antivirals for hepatitis C after curative ablation of hepatocellular carcinoma improves neoplastic recurrence-free survival","authors":"Ahmed A. Elhadidy, A. Selim, M. Sarhan, M. Mabrouk, Heba Samier, A. Elsawy","doi":"10.21608/jcbr.2021.64062.1182","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":428417,"journal":{"name":"International Journal of Cancer and Biomedical Research","volume":"80 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer and Biomedical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/jcbr.2021.64062.1182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}